Photronics Inc. (NASDAQ: PLAB) reported an insider sale on April 8, 2026, when Zhang Rui, who serves as Vice President, Chief Accounting Officer and Corporate Controller, sold 1,752 shares of the company's common stock at $43.50 per share, generating total proceeds of $76,212, according to a Form 4 filing with the Securities and Exchange Commission.
Following that disposition, Zhang directly holds 31,635 shares in Photronics. The sale comes while the stock has delivered a substantial 151% return over the last 12 months.
Separate company disclosures and research notes cited in available analysis indicate that PLAB currently appears overvalued relative to its Fair Value, per InvestingPro. Additional InvestingPro resources referenced for PLAB include 14 supplementary InvestingPro Tips and expanded Pro Research Reports that provide deeper company coverage.
Photronics also published quarterly operating results for fiscal Q1 2026 that exceeded analyst expectations. The company reported earnings per share of $0.61, above the consensus estimate of $0.5267, representing a 15.82% upside to forecasts. Revenue for the quarter was $225.07 million, modestly ahead of the $220.83 million analysts had anticipated, a 1.92% positive variance.
Operationally, Photronics announced plans to install an advanced mask writer at its Korea facility, with the equipment scheduled to be in place in fiscal Q2 2026. The new machine is intended to bolster production of AMOLED photomasks, including support for G8.6 mask sizes.
On the institutional research side, Craig-Hallum raised its price target for Photronics shares to $48 from $42 and reiterated a Buy rating. The firm cited Photronics' strategic position as semiconductor manufacturers increasingly outsource photomask production as a rationale for its outlook.
At its annual shareholder meeting, Photronics shareholders elected eight directors to the board and approved both the company’s auditor and executive compensation as presented.
This report compiles the transaction and the company developments disclosed in the filings and public company releases. Where available, referenced valuation commentary and analyst coverage are noted without additional interpretation beyond the cited statements.